Clinical Trial Update: TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating transarterial chemoembolization (TACE) combined with radiofrequency/multivessel (RFA/MV) treatment for hepatocellular carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Fudan University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: COMPLETED